Zimberelimab Plus Lenvatinib After Progression on Prior Immune Checkpoint Inhibitors for Advanced Cervical Cancer
Clinical trial NCT05824468 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05824468
- Sponsor
- Sun Yat-sen University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-10
- Primary completion
- 2024-07-20
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.